Standardizing Myopia Control - Scorecard - MDSpire

Standardizing Myopia Control

  • July 8, 2026

  • 4 min

Share

Clinical Scorecard: Standardizing Myopia Control

At a Glance

CategoryDetail
ConditionMyopia
Key MechanismsProgressive myopia leads to long-term risks including retinal detachment, glaucoma, and irreversible visual impairment.
Target PopulationChildren and young adults, particularly in the Asia-Pacific region.
Care SettingOphthalmology and optometry practices.

Key Highlights

  • Myopia prevalence in some Asia-Pacific countries reaches 95%.
  • Consensus recommendations for myopia control contact lenses include fitting children as young as five.
  • Routine monitoring for contact lenses should occur at three, six, and twelve months.
  • Orthokeratology requires more intensive follow-up than soft lenses.
  • Treatment success benchmarks include refractive progression of no more than 0.50 D annually.

Guideline-Based Recommendations

Diagnosis

  • Assess comfort, vision, centration, and primary gaze lens position during monitoring.

Management

  • Consider treatment discontinuation based on stability in refraction and axial length.

Monitoring & Follow-up

  • Follow-up visits for soft lenses at three, six, and twelve months; for orthokeratology at one day, one month, three months, and six months.

Risks

  • Potential long-term risks of progressive myopia include retinal detachment and irreversible visual impairment.

Patient & Prescribing Data

Children and young adults in the Asia-Pacific region.

Combination therapy with atropine may be used, with a recommended dose range of 0.01-0.05 percent.

Clinical Best Practices

  • Use trial lens fitting as the preferred approach for myopia control soft contact lenses.
  • Employ slit-lamp examination and corneal topography for orthokeratology assessments.
  • Set practical benchmarks for treatment success based on refractive progression and axial length increase.

Related Resources & Content

Original Source(s)

Related Content